NeuroSense Therapeutics
NRSN
5 hedge funds and large institutions have $380K invested in NeuroSense Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.42% more ownership
Funds ownership: 0% → 1.42% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$228K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$168K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$47.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.02K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Hudson Bay Capital Management
Stamford,
Connecticut
| $184K | +$228K | +75,000 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $135K | +$168K | +55,119 | New |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $38K | +$47.2K | +15,501 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $20K | +$24.4K | +8,018 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | +$4.02K | +1,323 | New |
|
NRSN Hedge Fund Activity: Q4 2021 in Review
5 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in NeuroSense Therapeutics (NRSN) for Q4 2021, worth a combined $380K.
Buyers outnumbered sellers: 5 funds opened new NRSN positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $228K.
- 5 institutional investors held NeuroSense Therapeutics (NRSN) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $380K of NeuroSense Therapeutics stock for Q4 2021.
- 5 funds opened new NeuroSense Therapeutics positions in Q4 2021 and 0 closed out, a net change of +5 holders.
- The largest NeuroSense Therapeutics buyer in Q4 2021 was Hudson Bay Capital Management, an estimated $228K added.
Based on aggregated 13F filings for Q4 2021.